Seneca House Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
2,093
+56
| +3% | +$10.4K | 0.17% | 61 |
|
|
2025
Q1 | $427K | Buy |
2,037
+6
| +0.3% | +$1.26K | 0.18% | 61 |
|
|
2024
Q4 | $361K | Sell |
2,031
-56
| -3% | -$9.95K | 0.14% | 70 |
|
|
2024
Q3 | $412K | Buy |
2,087
+47
| +2% | +$9.28K | 0.17% | 60 |
|
|
2024
Q2 | $350K | Buy |
2,040
+34
| +2% | +$5.83K | 0.15% | 64 |
|
|
2024
Q1 | $365K | Sell |
2,006
-5
| -0.2% | -$910 | 0.16% | 67 |
|
|
2023
Q4 | $312K | Sell |
2,011
-5
| -0.2% | -$775 | 0.14% | 64 |
|
|
2023
Q3 | $301K | Buy |
2,016
+27
| +1% | +$4.03K | 0.16% | 64 |
|
|
2023
Q2 | $268K | Hold |
1,989
| – | – | 0.13% | 70 |
|
|
2023
Q1 | $317K | Hold |
1,989
| – | – | 0.16% | 70 |
|
|
2022
Q4 | $321K | Hold |
1,989
| – | – | 0.18% | 70 |
|
|
2022
Q3 | $267K | Hold |
1,989
| – | – | 0.2% | 68 |
|
|
2022
Q2 | $305K | Sell |
1,989
-1
| -0.1% | -$153 | 0.2% | 72 |
|
|
2022
Q1 | $323K | Hold |
1,990
| – | – | 0.17% | 72 |
|
|
2021
Q4 | $269K | Buy |
1,990
+21
| +1% | +$2.84K | 0.14% | 75 |
|
|
2021
Q3 | $212K | Hold |
1,969
| – | – | 0.13% | 84 |
|
|
2021
Q2 | $222K | Hold |
1,969
| – | – | 0.14% | 79 |
|
|
2021
Q1 | $213K | Buy |
1,969
+24
| +1% | +$2.6K | 0.15% | 76 |
|
|
2020
Q4 | $208K | Buy |
+1,945
| New | +$208K | 0.15% | 76 |
|
|
2019
Q2 | – | Sell |
-5,405
| Closed | -$436K | – | 91 |
|
|
2019
Q1 | $436K | Sell |
5,405
-1,287
| -19% | -$104K | 0.38% | 64 |
|
|
2018
Q4 | $617K | Sell |
6,692
-171
| -2% | -$15.8K | 0.58% | 46 |
|
|
2018
Q3 | $649K | Buy |
6,863
+497
| +8% | +$47K | 0.51% | 53 |
|
|
2018
Q2 | $590K | Buy |
6,366
+2,550
| +67% | +$236K | 0.48% | 57 |
|
|
2018
Q1 | $361K | Buy |
3,816
+828
| +28% | +$78.3K | 0.3% | 75 |
|
|
2017
Q4 | $289K | Buy |
+2,988
| New | +$289K | 0.25% | 82 |
|